Likarda, LLC

[On Demand]
Likarda is a biotech company focused on becoming the leading cell formulation company for delivery systems that enable cell therapies to function optimally. Our technology provides a novel method to encapsulate cells using stealth biomaterials not sensed by the immune system, and the only company offering a degradable solution.

Likarda's technology is based on cell encapsulation and delivery in hydrogels using our patented CSS® (Core-Shell Spherification) system. Instead of utilizing or modifying alginate (which is basically a bandaid solution), Likarda utilizes readily available and biocompatible hydrogels such Hyaluronic Acid, PEG, and other chemistries creating a library of over 50 different formulations.

Primary classes of hydrogels:
+ Degradable: injectable cell therapies in a slow-release, degradable formulation enabling localization and increased efficacy.
+ Durable: coating the cells in an immunoprotective barrier for injection/transplant for longterm treatments.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Degradable Hydrogel Encapsulation Platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Chief Operating Officer
Likarda, LLC